AKT1 (also known as RAC-PK-alpha or Protein kinase B) is one of three closely related serine/threonine protein kinases (AKT1, AKT2, and AKT3) that constitute the AKT kinase family . AKT1 plays crucial roles in regulating diverse cellular processes including metabolism, proliferation, cell survival, growth, and angiogenesis . The protein is characterized by specific accession numbers (Swiss-Prot: P31749, NCBI Protein: NP_001014431.1) and gene ID 207 .
AKT1 mediates its effects through serine and/or threonine phosphorylation of numerous downstream substrates . The protein is central to insulin signaling, regulating glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface . Additionally, AKT1 regulates glycogen storage through phosphorylation of GSK3A at 'Ser-21' and GSK3B at 'Ser-9', inhibiting their kinase activity .
The AKT1 (Ab-308) Antibody has been validated for multiple applications, primarily Western blotting (WB) and immunohistochemistry (IHC) . The recommended dilutions for optimal results are as follows:
| Application | Recommended Dilution |
|---|---|
| Western Blotting | 1:500 - 1:1000 |
| Immunohistochemistry | 1:50 - 1:100 |
Scientific validation of the AKT1 (Ab-308) Antibody includes Western blot analysis of extracts from HepG2 and HeLa cells, demonstrating specificity for the target protein . These validation studies confirm the antibody's ability to recognize endogenous AKT1 in human cell lines, providing researchers with confidence in experimental applications.
The antibody is produced by immunizing rabbits with a synthetic peptide corresponding to amino acids 306-310 of human AKT1, conjugated to KLH (Keyhole Limpet Hemocyanin) carrier protein . This immunization strategy generates polyclonal antibodies with multiple epitope recognition capabilities, enhancing detection sensitivity.
Following immunization, the antibodies undergo affinity chromatography purification using epitope-specific peptides . This purification process ensures high specificity by selectively isolating antibodies that recognize the target epitope, reducing background signal and cross-reactivity in experimental applications.
The AKT1 (Ab-308) Antibody is rigorously tested to confirm its ability to detect endogenous levels of total AKT protein . Quality control measures include Western blot analysis against cell extracts from commonly used cell lines such as HepG2 and HeLa, demonstrating the expected 60 kDa band corresponding to AKT1 .
The antibody has confirmed reactivity with human, mouse, and rat samples, making it a versatile tool for comparative studies across these species . This cross-species reactivity facilitates translational research from animal models to human applications.
For Western blotting, optimal results are achieved at dilutions between 1:500 and 1:1000, while immunohistochemistry applications require dilutions of 1:50 to 1:100 . Researchers should optimize specific conditions for their particular experimental systems, considering sample type, antigen abundance, and detection method.
The AKT1 (Ab-308) Antibody, being rabbit-derived, is compatible with various anti-rabbit IgG secondary antibodies, including those conjugated to alkaline phosphatase (AP), biotin, fluorescent tags (FITC), or horseradish peroxidase (HRP) . Selection of appropriate secondary antibodies should align with the desired detection method and experimental design.
AKT1 is one of three closely related serine/threonine-protein kinases (AKT1, AKT2, and AKT3) collectively known as the AKT kinase family. These kinases regulate numerous cellular processes including:
Metabolism and glucose homeostasis
Cell proliferation and cell cycle progression
Cell survival and anti-apoptotic responses
Cellular growth and protein synthesis
Angiogenesis
AKT1 mediates these functions through serine and/or threonine phosphorylation of over 100 downstream substrate candidates. The protein plays a central role in insulin signaling, glucose metabolism, and cell survival pathways .
The AKT1 (Ab-308) Antibody specifically recognizes a peptide sequence around amino acids 306-310 (M-K-T-F-C) of the human AKT1 protein. This region is located near the T308 phosphorylation site, which is one of the key regulatory sites for AKT1 activation . The antibody is designed to detect AKT1 regardless of its phosphorylation status, making it useful for measuring total AKT1 protein levels .
The T308 phosphorylation site of AKT1 is critical for its activation. When developing or selecting antibodies, it's important to understand that:
Phospho-specific antibodies (like those against phospho-T308) specifically detect only the phosphorylated form of AKT1
The AKT1 (Ab-308) Antibody recognizes a region near but not identical to the T308 phosphorylation site
For comprehensive AKT1 signaling studies, researchers often need both total AKT1 antibodies and phospho-specific antibodies to calculate activation ratios
For optimal Western Blot results with AKT1 (Ab-308) Antibody:
| Parameter | Recommendation |
|---|---|
| Dilution | 1:500 - 1:1000 |
| Expected Band Size | Approximately 56 kDa |
| Sample Types | Cell lysates (HepG2, HeLa, etc.) |
| Blocking | 5% non-fat milk or BSA in TBST |
| Secondary Antibody | Anti-rabbit IgG conjugated to HRP |
| Exposure Method | Either chemiluminescence or fluorescence detection |
For phosphorylation studies, remember to include phosphatase inhibitors in your lysis buffer to preserve phosphorylation status. Additionally, when studying AKT1 activation, parallel blots with phospho-specific antibodies (pT308, pS473) should be performed to assess activation status .
For immunohistochemistry applications:
| Parameter | Recommendation |
|---|---|
| Dilution | 1:50 - 1:200 |
| Sample Preparation | Fresh frozen tissues preferred over paraffin-embedded |
| Antigen Retrieval | Citrate buffer (pH 6.0) heat-induced retrieval |
| Detection System | Polymer-based or avidin-biotin detection systems |
| Controls | Include positive controls (tissues known to express AKT1) and negative controls |
Note: The antibody has been validated for mouse, rat, and human tissues. For other species, preliminary testing is recommended due to the sequence homology (the immunogen shows 85% identity to mouse and 92% identity to rat AKT1) .
AKT1 activation involves a multi-step phosphorylation cascade:
Initial phosphorylation at Thr450 by JNK kinases
Phosphorylation at Thr308 by PDK1 (in the activation loop)
Phosphorylation at Ser473 by PDK2 or mTORC2 (in the C-terminal regulatory domain)
To properly monitor this activation cascade:
Use phospho-specific antibodies against each site
Implement time-course experiments after stimulation
Compare phosphorylation patterns across different stimuli
Correlate phosphorylation with downstream substrate activation
Research has shown that Thr308 phosphorylation is necessary and sufficient for AKT1 activation, while Ser473 phosphorylation enhances this activity and might direct substrate specificity .
Recent research has revealed that AKT1 methylation plays a crucial role in its activation:
AKT1 is methylated in its linker region by the histone methyltransferase SETDB1
This methylation is antagonized by the demethylase KDM4B
Methylation promotes the interaction of AKT1 with PDK1, enhancing Thr308 phosphorylation
Methylation-deficient AKT1 mutants (K140/142R) show:
Reduced interaction with PDK1
Diminished binding to PtdIns(3,4,5)P3
Decreased association with the cell membrane
This indicates that methylated AKT1 has a greater propensity to bind PtdIns(3,4,5)P3, promoting membrane localization where it can be phosphorylated by PDK1 .
To study the AKT1 interactome and its cell cycle-dependent associations:
Experimental approach: Use affinity purification coupled with mass spectrometry (AP-MS) as demonstrated in studies identifying 213 AKT1 interacting partners
Cell cycle synchronization protocols:
G0 arrest: Serum starvation (overnight)
G1/S arrest: Aphidicolin treatment
G2/M arrest: Nocodazole treatment
Validation strategies:
Co-immunoprecipitation followed by western blot
Reverse co-immunoprecipitation
siRNA knockdown of interacting partners to assess functional consequences
Studies have shown that 32 proteins exhibit varying association with AKT1 across different cell cycle stages, suggesting stage-specific regulatory mechanisms .
Several factors can contribute to inconsistent AKT1 detection:
| Issue | Possible Cause | Solution |
|---|---|---|
| Weak or no signal | Insufficient protein | Increase protein loading or concentrate samples |
| Inefficient transfer | Optimize transfer conditions for high MW proteins | |
| Antibody degradation | Use fresh aliquots; avoid freeze-thaw cycles | |
| Multiple bands | Post-translational modifications | Use isoform-specific antibodies; include phosphatase treatment |
| Cross-reactivity with AKT2/3 | Use AKT1-specific antibodies; validate with knockout controls | |
| Inconsistent results between experiments | Variable activation states | Standardize cell stimulation protocols |
| Different lysis methods | Use consistent lysis buffers with appropriate inhibitors |
Remember that AKT1 expression can be comparable across different cell cycle stages, but its phosphorylation and interaction partners may vary significantly .
Distinguishing between the three AKT isoforms requires careful experimental design:
Antibody selection: Use isoform-specific antibodies that target unique regions
AKT1 (Ab-308) targets a sequence specific to AKT1
Verify antibody specificity against recombinant AKT isoforms
Genetic approaches:
siRNA/shRNA knockdown of specific isoforms
CRISPR/Cas9-mediated knockout validation
Rescue experiments with isoform-specific constructs
Expression analysis:
RT-qPCR for isoform-specific mRNA expression
Tissue/cell-type selection (AKT3 is more restricted to brain tissues)
Functional assays:
Advanced applications for studying AKT1 in cell cycle regulation include:
Temporal analysis of AKT1 interactions:
Use SILAC (Stable Isotope Labeling with Amino acids in Cell culture) coupled with immunoprecipitation to quantify dynamic changes in AKT1 interactome across cell cycle stages
Compare protein associations in G0, G1/S, and G2/M phases
Functional validation of interactors:
Employ siRNA-mediated silencing of AKT1-interacting proteins
Measure effects on population doubling time (PDT)
Analyze cell cycle distribution by flow cytometry
Pathway integration analysis:
Combine AKT1 interactome data with phosphoproteomics
Map interactions to known regulatory pathways for protein synthesis and metabolism
Research has shown that AKT1 overexpression decreases population doubling time by approximately 4.92 hours compared to normal cells, confirming its functional role in driving cell cycle progression .
Cutting-edge techniques for studying AKT1 phosphorylation dynamics include:
Phospho-flow cytometry:
Single-cell analysis of phosphorylated AKT1 using fluorescent-conjugated antibodies
Allows for heterogeneity assessment within cell populations
Can be combined with cell cycle markers for multiparametric analysis
Live-cell imaging with phospho-sensors:
FRET-based biosensors to monitor AKT1 phosphorylation in real-time
Optogenetic tools to induce targeted AKT1 activation
Mass spectrometry-based approaches:
Targeted quantitative phosphoproteomics
Parallel reaction monitoring (PRM) for site-specific phosphorylation quantification
Crosslinking mass spectrometry to capture transient interactions
Spatial phosphorylation analysis:
These techniques provide unprecedented insight into the spatial and temporal dynamics of AKT1 phosphorylation and its relationship to cellular function and disease states.